What’s Next for BIONIK LABORATORIES CORPORATION (OTCMKTS:BNKL) After Having Less Shares Shorted?

June 19, 2017 - By Kurt Siggers

The stock of BIONIK LABORATORIES CORPORATION (OTCMKTS:BNKL) registered a decrease of 68.35% in short interest. BNKL’s total short interest was 2,500 shares in June as published by FINRA. Its down 68.35% from 7,900 shares, reported previously.

It closed at $0.267 lastly. It is down 0.00% since June 19, 2016 and is . It has underperformed by 16.70% the S&P500.

Bionik Laboratories Corp. , formerly Drywave Technologies, Inc., is a medical device and robotics company. The company has market cap of $12.61 million. The Firm is focused on providing rehabilitation solutions and developing transformational technologies and solutions to individuals with neurological disorders, specializing in the designing, developing and commercializing of physical rehabilitation technologies, prosthetics and assisted robotic products. It currently has negative earnings. It has over three products on the market and approximately three products in various stages of development.

More notable recent Bionik Laboratories Corp (OTCMKTS:BNKL) news were published by: Marketwatch.com which released: “0.267” on April 15, 2015, also Prnewswire.com with their article: “Bionik Laboratories Announces Closing of Acquisition of Interactive Motion …” published on April 21, 2016, Prnewswire.com published: “Bionik Laboratories Enters into Merger Agreement to Acquire Interactive Motion …” on March 07, 2016. More interesting news about Bionik Laboratories Corp (OTCMKTS:BNKL) were released by: Prnewswire.com and their article: “Bionik Laboratories Commences Trading on OTCQX under Ticker Symbol BNKL” published on August 19, 2015 as well as Streetinsider.com‘s news article titled: “Form 8-K Bionik Laboratories Corp For: May 25” with publication date: May 25, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.